Fierce Pharma

SEPTEMBER 20, 2024

After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with the progressive disease suddenly have two new options, with more likely o | Regeneron and Sanofi have announced that the FDA has expanded the label of megablockbuster Dupixent to treat COPD. With the nod, Dupixent becomes the first biologic treatment for COPD patients in the U.S.

FDA 321

FDA Patients 321

MedCity News

SEPTEMBER 20, 2024

Zevra Therapeutics drug Miplyffa is now FDA approved for Niemann-Pick disease type C, a lysosomal storage disorder. The affirmative regulatory decision took into account additional clinical data generated since the FDA turned down a submission for the drug in 2021. The post FDA Approval Makes a Zevra Drug the First Therapy for Rare and Fatal Metabolic Disease appeared first on MedCity News.

FDA 126

FDA Biopharma Pharma 126

Fierce Pharma

SEPTEMBER 20, 2024

The hits just keep on coming for Bristol Myers Squibb staffers amid the company's cost-savings program. | Bristol Myers Squibb is laying off an additional 79 staffers in Lawrenceville, New Jersey. The cuts will be effective between Dec. 12 and May 30 of next year and are part of BMS's $1.5 billion cost reduction program.

299

299

MedCity News

SEPTEMBER 20, 2024

Many are already experimenting with AI in narrow settings. But in order to expand deployment, it’s important to understand the most practical AI opportunities with the greatest ROI. Here are four high-impact opportunities that can boost staff efficiency and improve the patient experience. The post From Charting to Patient Intake: The 4 Biggest Opportunities for AI in Healthcare appeared first on MedCity News.

Healthcare 126

Healthcare Healthcare Patients 126

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

SEPTEMBER 20, 2024

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday. | Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday.

FDA 290

FDA Patients 290

MedCity News

SEPTEMBER 20, 2024

Meditech is integrating Suki’s AI assistant into more than a dozen rural health systems, including St. Mary’s Healthcare in New York and Decatur County Memorial Hospital in Indiana. The post When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This appeared first on MedCity News.

Doctors 120

Doctors Healthcare Healthcare 120

MedCity News

SEPTEMBER 20, 2024

In two letters, U.S. representatives and senators called for an extension of the enhanced premium tax credits, which are set to expire in 2025 and have lowered costs for those purchasing coverage on the marketplace. The post 195 Congress Members Call for Extension of Enhanced Premium Tax Credits appeared first on MedCity News.

118

118

Fierce Pharma

SEPTEMBER 20, 2024

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on AstraZeneca's influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17. With the green light, FluMist is now the only flu vaccine in the U.S. patients can give to themselves.

FDA 279

FDA Patients 279

MedCity News

SEPTEMBER 20, 2024

We need to continue investing in research for early stage, localized prostate cancer, develop treatments that balance efficacy with quality-of-life considerations, ensure diverse representation in clinical trials, and listen to patients and incorporate their perspectives into treatment development and decision-making. The post Prostate Cancer Management – We Need Better Options for Early-Stage Disease appeared first on MedCity News.

Management 116

Management Patients Physicians 116

Fierce Pharma

SEPTEMBER 20, 2024

Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of AstraZeneca’s Tagrisso in non-small cell lung cancer (NSCLC). | Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of AstraZeneca’s Tagrisso in non-small cell lung cancer (NSCLC).

FDA 279

FDA Patients 279

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

SEPTEMBER 20, 2024

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

Healthcare 115

Healthcare Healthcare 115

Fierce Pharma

SEPTEMBER 20, 2024

Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been left in the cold once again. | Europe’s Committee for Medicinal Products for Human Use has confirmed its negative stance on pegcetacoplan in geographic atrophy, an advanced form of age-related macular degeneration that can lead to blindness.

Prospecting 278

Prospecting Medicine Leads Pharmaceutical 278

pharmaphorum

SEPTEMBER 20, 2024

Astellas is ready to launch its first digital health product in the US, called Digitiva, which provides at-home monitoring of people with heart failure

115

115

Fierce Pharma

SEPTEMBER 20, 2024

Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA manufacturing observations aliu Fri, 09/20/2024 - 09:21

Manufacturing 251

Manufacturing Pharma FDA 251

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

SEPTEMBER 20, 2024

The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.

Management 105

Management 105

pharmaphorum

SEPTEMBER 20, 2024

J&J's target of $5bn in sales for Rybrevant has moved a step closer, after an FDA approval for second-line treatment of EGFR+ NSCLC

FDA 105

FDA Sales 105

MedCity News

SEPTEMBER 20, 2024

Active investors chose Healthy Young Minds as the Pitch Perfect winner at the INVEST Digital Health Conference in Dallas. See how the company’s CEO accepted the award. The post Video: INVEST Digital Health Pitch Perfect Winner Accepting Award appeared first on MedCity News.

104

104

pharmaphorum

SEPTEMBER 20, 2024

Job losses loom at Achilles as TIL therapy platform is cut Phil.

59

59

Advertisement

Pharmacy Times

SEPTEMBER 20, 2024

The rare disease can result in progressive neurological symptoms and organ complications.

FDA 55

FDA 55

PharmaTech

SEPTEMBER 20, 2024

The announcement of the pairing comes several months after Adare Pharma Solutions said it would upgrade several of its facilities, including in Milan, Italy, where the 3D printing operations will be located.

Pharma 52

Pharma 52

Pharmacy Times

SEPTEMBER 20, 2024

Shifting from a vertical, isolated care model into a collaborative approach can improve the clinician and patient experience.

Prescription 54

Prescription Patients Medical 54

Pharmaceutical Commerce

SEPTEMBER 20, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Kevin MacDonald, Bluesight’s Co-founder and CEO, discusses why mitigating the impact of rising costs is imperative, while explaining the benefit of advanced analytics tools.

Pharma 52

Pharma 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmacy Times

SEPTEMBER 20, 2024

The decision expands treatment options for patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM).

FDA 52

FDA Patients 52

PharmaTech

SEPTEMBER 20, 2024

Vectura’s expertise in the field includes formulation and device development for dry powder inhalers and pressurized metered dose inhalers, among other products and services.

52

52

Pharmacy Times

SEPTEMBER 20, 2024

Dermatomal reactions could occur following recombinant zoster vaccine to treat shingles.

52

52

Pharmaceutical Commerce

SEPTEMBER 20, 2024

A study examines if this PCP-large health system dynamic impacts patient outcomes.

Patients 52

Patients 52

Advertisement

Distribution

Pharmacy Times

SEPTEMBER 20, 2024

Amivatamab-vmjw is a fully-human bispecific antibody targeting EGFR and MET with immune cell-directed activity.

FDA 52

FDA 52

PharmaTech

SEPTEMBER 20, 2024

In this video, hear Albert McEvoy, Senior Director of NORAM Logistics, talk about how Marken is preparing its pharma supply chains for a new age of healthcare by optimizing drug development and delivery through cutting-edge tech, strategic partnerships, and contingency plans ― a future where patients anywhere in the world have access to essential medicines.

Pharma 52

Pharma Medicine Healthcare Healthcare 52

Pharmacy Times

SEPTEMBER 20, 2024

The use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.

52

52

PharmaTech

SEPTEMBER 20, 2024

The collaboration is designed to combine NanoVation Therapeutics’ lipid nanoparticle technology for RNA delivery to cells outside the liver with Novo Nordisk’s knowledge of cardiometabolic and rare disease R&D.

Medicine 52

Medicine 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales